Navigation Links
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Date:4/8/2008

an, Australia and New Zealand.

"We are delighted to enter into this transaction with Zoticon, which shares our vision in the potential of Virulizin(R) and has the expertise and financial commitment to bring Virulizin(R) to market," stated Dr. Aiping Young, President and Chief Executive Officer of Lorus. "We believe that this drug has significant potential as a treatment option not only for patients with advanced pancreatic cancer, one of the most difficult cancers to treat, but also, upon further development, for other cancer indications. This arrangement provides significant potential value to our shareholders, representing Lorus' commitment in maximizing the commercial potential of its anticancer products."

"Zoticon is very excited to be involved with the Virulizin(R) program. We have already begun to lay the groundwork for Zor Pharmaceuticals to continue product development and ultimately commercialization of this novel drug," stated Asher Nathan, Managing Director of Zoticon.

Lorus invites analysts and media to participate in a conference call on April 9, 2008 at 3:00 pm Eastern Time. Shareholders are invited to listen to the call by telephone and the call will be available on the website (http://www.lorusthera.com/) following completion. Dial in numbers are below:
Toronto: 1-416-644-3422

Toll-free: 1-800-732-0232

About Virulizin(R)

------------------ Virulizin(R) is a novel biological response modifier (or immunotherapeutic agent) that stimulates a patient's immune system through several mechanisms, including the activation of macrophages and the infiltration of natural killer cells into tumors. Virulizin(R) has demonstrated high levels of antitumor activity against a number of cancer indications including pancreatic cancer. Virulizin(R) has been granted orphan drug status and fast track status from the United States FDA and orphan designation from the M
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
7. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
...HAI On day four of Gov. Jim Doyle,s trade mission...gy and software company, signed two major agreemen...rship is expected to result in new investments wor...f new jobs in Wisconsin. , ,"This deal shows the t...nies to play a role as China is rapidly upgrading ...
... are three locations on an Internet search page: t...me fits onto a single page and other times its 100...: If your Web sites identity is successful, only t...le to potential customers. However, if its submerg...ysterious undercurrents or worse, rest at the bott...
...ON The national AFL-CIO has taken its Show on the...ing too many jobs overseas, the labor union organi... the Jobs . , ,Laid-off workers, students, a pries...mong the 51 people who toured Wisconsin and seven ...y the Bush administration to promote a growing eco...
...n on investment has become a national obsession. L...t. But in many organizations ROI has become more o...ot always clear who is in the drivers seat. Becaus... through organizations, squashing otherwise approp...of the way. Some organizations throw away the keys...
Other Biology Technology:Does your web site have visibility? 2Does your web site have visibility? 3Theres a surprising, and positive, side to the offshore jobs debate 2Theres a surprising, and positive, side to the offshore jobs debate 3Make ROI work for you 2Make ROI work for you 3
(Date:10/6/2008)...ELPHIA Moderate consumption of red wine may decre... report in the October issue of Cancer Epidemiolo...ican Association for Cancer Research. , "An ant...f lung cancer, particularly among smokers," said C...rmanente ,Department of Research and Evaluation i...
(Date:10/6/2008)... Hughes Medical Institute researchers have develop...ted Down syndrome and two other serious chromosoma...f confirmed in larger trials, they say, the test w...ive prenatal tests such as amniocentesis that pose...ong known that a pregnant woman,s blood contains s...
(Date:10/6/2008)...ne,s for the birds. , A study by biologists at Wa...re diverse a bird population is in an area, the le...us (WNV). , Now, let,s hear it for the birds. , ... species in your backyard, you have much lower ris...n, doctoral candidate in biology in Arts & Science...
(Date:10/6/2008)... What does a mixture of two different kinds of ce...? The same basic force causes both mixtures to sep...onclusion of a new three-dimensional computer mode...tson, assistant professor of physics at Vanderbilt...of Waterloo in Canada that is described in the Oct...
Breaking Biology News(10 mins):Red wine may lower lung cancer risk 2New blood test for Down syndrome 2New blood test for Down syndrome 3New blood test for Down syndrome 4Study: Bird diversity lessens human exposure to West Nile Virus 2Surface tension drives segregation within cell mixtures 2AMDL Updates Q2 and FY2008 Guidance 6883 1AMDL Updates Q2 and FY2008 Guidance 6883 2AMDL Updates Q2 and FY2008 Guidance 6883 3GKSS membranes reduce air pollution in Beijing 4306 1GKSS membranes reduce air pollution in Beijing 4306 2China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 1China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 2China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 3VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 2
... a newly marketed vaccine promises to drastically ... major cause of cervical cancer, a new discovery b...could some day help the millions of people already...d cancer. , One study found that 75 percent of sex...had, an HPV infection, while 10,000 women annually...
... flies, ability to discern one sex from another ma... of nerve cells, and the number of receptors is co... University of Illinois at Chicago researchers hav...ate, perceive and learn to debilitating illnesses ...strophy, post-traumatic stress syndrome and schizo...
...standing how the human brain learns to perceive ob...ience. In 2003, Pawan Sinha, a professor at the M...initiative with the hopes of shedding some light o...s "Project Prakash" is to find, treat, and study c...e study that resulted from this project appears in...
...tists at Queensland University of Technology are o... to protect women against contracting the most com...ernational vaccine company Sanofi-Pasteur has awar...ontinue its research into Chlamydia and work towar...lescent women. , Professor Peter Timms, from QU...
Other Biology News:Synthetic peptide targets latent papilloma virus infections 2Synthetic peptide targets latent papilloma virus infections 3Synthetic peptide targets latent papilloma virus infections 4Bisexual fruit flies show new role for neurochemical 2Chlamydia vaccine a step closer to reality 2
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface.
Antibeta-lactoglobulin monoclonal antibody(CD-2)
MAb to Vasopressin Preservative: NaN3
...α, clone 8G8/5 GenBank Accession Number : N...lpha/gamma fusion protein corresponding to residue...0 of human AP-2γ Formulation: 0.1M Tris-glyc... the addition of glycerol to 30% Quality Assurance...
Biology Products: